Stay updated on RC48-ADC in HER2+ Biliary Cancer Clinical Trial
Sign up to get notified when there's something new on the RC48-ADC in HER2+ Biliary Cancer Clinical Trial page.

Latest updates to the RC48-ADC in HER2+ Biliary Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe record history now reflects the latest platform revision v3.6.5, replacing the previous v3.6.4. This is an administrative update recorded in the page history, with no change to study data or core content.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedNew revision entry Revision: v3.6.4 was added to the record history, and the previous Revision: v3.6.3 entry was removed. This reflects a small update to the page's history log rather than changes to the study content.SummaryDifference0.1%

- Check50 days agoChange DetectedThe study record history now shows a new release tag Revision: v3.6.3, replacing the previous v3.6.2. This reflects a minor update to the page's metadata rather than any substantive changes to the study content or displayed information.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision history now shows an added entry for Revision: v3.6.2 and removes Revision: v3.6.0, updating the visible version trail of this study record.SummaryDifference0.1%

- Check72 days agoChange DetectedThe study record history adds a Last verified field and a Last known status was entry, and the revision label updates to v3.6.0, replacing the previous v3.5.5.SummaryDifference2%

- Check79 days agoChange DetectedA new release entry 'Revision: v3.5.5' is added to the history, replacing the previous 'Revision: v3.5.4' entry. This reflects a software release update for the page rather than changes to the study data or descriptions.SummaryDifference0.1%

Stay in the know with updates to RC48-ADC in HER2+ Biliary Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RC48-ADC in HER2+ Biliary Cancer Clinical Trial page.